Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 50090-7078

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 50090-7078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907078)

Label for lurasidone hydrochloride 20 mg film-coated tablets from A-S Medication Solutions. The label indicates each tablet contains 20 mg of lurasidone hydrochloride, provides storage instructions to keep at 77 degrees Fahrenheit, and notes a quantity of 30 tablets. The label also includes the product NDC 50090-7078-0 and a disclaimer to see the package insert for dosage information.*

FDA Label Image

Lurasidone-fig1.jpg (Lurasidone Fig1)

A chart showing the impact of other drugs on the pharmacokinetics of lurasidone, illustrating fold change and 90% confidence intervals in Cmax and AUC. The chart compares strong and moderate CYP3A4 inhibitors (ketoconazole, diltiazem) and strong CYP3A4 inducers (rifampin, lithium) relative to lurasidone alone with changes plotted on a horizontal axis.*

FDA Label Image

Lurasidone-fig2.jpg (Lurasidone Fig2)

A forest plot chart showing fold change and 90% confidence intervals (CIs) for pharmacokinetic parameters (Cmax, AUC, or Ctrough) of various interacting drugs relative to their administration alone. The drugs include digoxin, midazolam, ethinyl estradiol, norelgestromin, and lithium, plotted along a horizontal axis representing change values from -1.0 to 1.0.*

FDA Label Image

Lurasidone-fig3.jpg (Lurasidone Fig3)

A pharmacokinetic chart depicting fold change and 90% confidence intervals for lurasidone hydrochloride 20 mg film-coated tablet. It compares Cmax and AUC values under conditions of renal and hepatic impairment (mild, moderate, severe) and across population subgroups by gender and race (including Asian), displaying changes relative to reference values.*

FDA Label Image

Lurasidone-str.jpg (Lurasidone Str)

Chemical structure of lurasidone hydrochloride, showing detailed molecular bonds and arrangement of atoms typical for this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.